SCHEMBL6325580

SCHEMBL6325580

CCCC(CNC=O)Oc1ccc(OC)cc1

nearest known ligand 0.44

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TAS1R3 Q7RTX0 6/20 0.44
TAS1R1 Q7RTX1 6/20 0.44
GSK3B P49841 1/20 0.41
MTNR1A P48039 1/20 0.40
MTNR1B P49286 1/20 0.40
MMP1 P03956 1/20 0.38
MMP13 P45452 1/20 0.38
TDP1 Q9NUW8 1/20 0.37
ALDH1A1 P00352 1/20 0.37
CYP2A6 P11509 1/20 0.37
SLC6A2 P23975 1/20 0.35
SLC6A4 P31645 1/20 0.35
SLC6A3 Q01959 1/20 0.35
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
HTT P42858 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6326788 0.88 KMT2A (0.35) TAS1R3TAS1R1ALDH1A1CA2
SCHEMBL6327965 0.81 SMN1; SMN2 (0.44) TAS1R3TAS1R1TDP1SMN1; SMN2
SCHEMBL20324943 0.80 CA1 (0.48) TAS1R3TAS1R1MTNR1AMTNR1BMMP1
SCHEMBL20041847 0.72 FFAR1 (0.45) TAS1R3TAS1R1ALDH1A1CYP2A6CA1
Hydrochloric Acid SCHEMBL11567286 0.71 TDP1 (0.33) TDP1ALDH1A1
SCHEMBL3443780 0.70 AOC3 (0.63) TDP1ALDH1A1SLC6A4SLC6A3SMN1; SMN2
SCHEMBL4723219 0.69 CNR2 (0.49) TDP1ALDH1A1HTTSMN1; SMN2
SCHEMBL8372736 0.68 ALDH1A3 (0.50) ALDH1A1CYP2A6SMN1; SMN2
SCHEMBL11035722 0.67 PPARG (0.35) TAS1R3TAS1R1MMP1MMP13SLC6A4
SCHEMBL8932490 0.67 EPHX1 (0.44) ALDH1A1HTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1501830-A1 7-ARYL-3,9-DIAZABICYCLO[3.3.1]NON-6-ENE DERIVATIVES AND THEIR USE AS RENIN INHIBITORS IN THE TREATMENT OF HYPERTENSION, CARDIOVASCULAR OR RENAL DISEASES Actelion Pharmaceuticals Ltd. (CH) 2005-02-02 EP disclosed
WO-2003093267-A1 7-ARYL-3,9-DIAZABICYCLO(3.3.1)NON-6-ENE DERIVATIVES AND THEIR USE AS RENIN INHIBITORS IN THE TREATMENT OF HYPERTENSION, CARDIOVASCULAR OR RENAL DISEASES ACTELION PHARMACEUTICALS LTD (CH) 2003-11-13 WO disclosed